These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7453567)

  • 41. Pharmacological treatment of obesity.
    Sullivan AC; Comai K
    Int J Obes; 1978; 2(2):167-89. PubMed ID: 30732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
    Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
    Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation and treatment of obesity.
    Azar ST; Zantout MS
    J Med Liban; 2000; 48(5):310-4. PubMed ID: 12489585
    [No Abstract]   [Full Text] [Related]  

  • 44. Impact of weight loss achieved through a multidisciplinary intervention on appetite in patients with severe obesity.
    Coutinho SR; Rehfeld JF; Holst JJ; Kulseng B; Martins C
    Am J Physiol Endocrinol Metab; 2018 Jul; 315(1):E91-E98. PubMed ID: 29360396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obesity: pathophysiology and practical management.
    Elliot DL; Goldberg L; Girard DE
    J Gen Intern Med; 1987; 2(3):188-98. PubMed ID: 3295151
    [No Abstract]   [Full Text] [Related]  

  • 46. [Short-term treatment of obesity: comparison between anorexigens and behavior modification].
    Hernández A; de los Angeles Saavedra M
    Rev Med Chil; 1984 Feb; 112(2):132-8. PubMed ID: 6740020
    [No Abstract]   [Full Text] [Related]  

  • 47. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.
    Astell KJ; Mathai ML; McAinch AJ; Stathis CG; Su XQ
    Complement Ther Med; 2013 Jun; 21(3):180-9. PubMed ID: 23642949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measuring success in the reduction of obesity in childhood. Limited weight reduction success among 50 ouptatients.
    Alley RA; Narduzzi JV; Robbins TJ; Weir TF; Sabeh G; Danowski TS
    Clin Pediatr (Phila); 1968 Feb; 7(2):112-8. PubMed ID: 5635611
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
    Geyer G; Haidinger G; Francesconi M; Langmayr N; Prager R; Schoberberger R; Toplak H; von Kalckreuth G; Kunze M
    Acta Med Austriaca; 1995; 22(5):95-101; 104-9. PubMed ID: 8651045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of a cellulose-containing weight-loss supplement on gastric emptying and sensory functions.
    Berthold HK; Unverdorben S; Degenhardt R; Unverdorben M; Gouni-Berthold I
    Obesity (Silver Spring); 2008 Oct; 16(10):2272-80. PubMed ID: 18719632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapy of obesity].
    Hunecke I
    Z Arztl Fortbild (Jena); 1980 Jul; 74(13-14):609-13. PubMed ID: 7434796
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients].
    Cairella M; Marchini G
    Clin Ter; 1995 Apr; 146(4):269-74. PubMed ID: 7796558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term effects of consumption of a novel fat emulsion in relation to body-weight management.
    Diepvens K; Soenen S; Steijns J; Arnold M; Westerterp-Plantenga M
    Int J Obes (Lond); 2007 Jun; 31(6):942-9. PubMed ID: 17299383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of nighttime feeding of carbohydrate or protein combined with exercise training on appetite and cardiometabolic risk in young obese women.
    Ormsbee MJ; Kinsey AW; Eddy WR; Madzima TA; Arciero PJ; Figueroa A; Panton LB
    Appl Physiol Nutr Metab; 2015 Jan; 40(1):37-45. PubMed ID: 25409324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
    Sabuncu T; Ucar E; Birden F; Yasar O
    Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute administration of capsaicin increases resting energy expenditure in young obese subjects without affecting energy intake, appetite, and circulating levels of orexigenic/anorexigenic peptides.
    Rigamonti AE; Casnici C; Marelli O; De Col A; Tamini S; Lucchetti E; Tringali G; De Micheli R; Abbruzzese L; Bortolotti M; Cella SG; Sartorio A
    Nutr Res; 2018 Apr; 52():71-79. PubMed ID: 29530622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Value of VLCD supplementation with medium chain triglycerides.
    Krotkiewski M
    Int J Obes Relat Metab Disord; 2001 Sep; 25(9):1393-400. PubMed ID: 11571605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.
    Hung YJ; Chen YC; Pei D; Kuo SW; Hsieh CH; Wu LY; He CT; Lee CH; Fan SC; Sheu WH
    Diabet Med; 2005 Aug; 22(8):1024-30. PubMed ID: 16026368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.